RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Metabolic and Endocrinology Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Post ADA Diabetes Treatment Market Assessment
Jun 2008 - $2,500
Ligand Pharmaceuticals Incorporated – Product Pipeline Review – Q4 2010
Dec 2010 - 93 pages - $500
Ipsen S.A. (IPN) - Financial and Strategic SWOT Analysis Review
Feb 2011 - 41 pages - $125
Tercica Inc: Premium Company Profile
Dec 2007 - 56 pages - $495
Versartis, Inc. – Product Pipeline Review – H2 2011
Oct 2011 - 41 pages - $500
Sanofi-Aventis Acquires Genzyme Corporation for $20 billion - Deal Analysis from GlobalData
May 2011 - 5 pages - $500
Company Financials: Eli Lilly and Company
Jan 2010 - $75
Growth Disorders - Pipeline Review, Q1 2011
Feb 2011 - 36 pages - $500
Ipsen S.A. (IPN) - Financial and Strategic SWOT Analysis Review
May 2011 - 42 pages - $125
More Related Market Research Reports >>>

Your selection

Therapeutic target
Endocrinology del
Hypothalamic del
Development phase
Phase II del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us